Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Eton Pharmaceuticals Q1 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $17.28M Beat $15.13M Estimate

Author: Benzinga Newsdesk | May 13, 2025 04:05pm
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. The company reported quarterly sales of $17.28 million which beat the analyst consensus estimate of $15.13 million by 14.22 percent. This is a 116.95 percent increase over sales of $7.97 million the same period last year.

Posted In: ETON


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist